Michelle Renee Griffin Adaptive Biotechnologies Corp (ADPT) insider trading activity

Michelle Renee Griffin is Director of Adaptive Biotechnologies Corp. Currently has a direct ownership of 15,394 shares of ADPT, which is worth approximately $194,888. The most recent transaction as insider was on Feb 14, 2021, when has been sold 1,504 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.4K

0% 3M change

70.37% 12M change

Total Value Held $194,888

MICHELLE RENEE GRIFFIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 14 2021	BUY Grant, award, or other acquisition	-	1,504 Added 50.0%	1,504 Common Stock
Jan 14 2021	SELL Open market or private sale	$396,600 $66.1 p/Share	6,000 Reduced 100.0%	0 Common Stock
Jan 14 2021	BUY Exercise of conversion of derivative security	$46,800 $7.8 p/Share	6,000 Added 50.0%	6,000 Common Stock
Dec 14 2020	SELL Open market or private sale	$351,660 $58.61 p/Share	6,000 Reduced 100.0%	0 Common Stock
Dec 14 2020	BUY Exercise of conversion of derivative security	$46,800 $7.8 p/Share	6,000 Added 50.0%	6,000 Common Stock
Nov 16 2020	SELL Open market or private sale	$287,580 $47.93 p/Share	6,000 Reduced 100.0%	0 Common Stock
Nov 16 2020	BUY Exercise of conversion of derivative security	$46,800 $7.8 p/Share	6,000 Added 50.0%	6,000 Common Stock
Oct 14 2020	SELL Open market or private sale	$633,360 $52.78 p/Share	12,000 Reduced 100.0%	0 Common Stock
Oct 14 2020	BUY Exercise of conversion of derivative security	$93,600 $7.8 p/Share	12,000 Added 50.0%	12,000 Common Stock

Also insider at

KDNY

CHINOOK THERAPEUTICS, INC. Healthcare

Director

ACER

Acer Therapeutics Inc. Healthcare

Director

HTGM

HTG MOLECULAR DIAGNOSTICS, INC Healthcare

Director

MRG